Christophe Arbet-Engels
CIK 1802615 · Chief Medical Officer · last filed 2025-10-03
Christophe Arbet-Engels is a Chief Medical Officer who has filed 8 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for ALT, was dated Oct 3, 2025. Across all open-market trades the lifetime net is −$5.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.46M
3
8
-$5.3K
Holdings By Company
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-03 | ALT | Grant (A) | — | $0 | EDGAR |
| 2025-02-14 | XFOR | Grant (A) | +850,000 | $0 | EDGAR |
| 2025-01-27 | XFOR | Mixed | +14,207 | -$5.3K | EDGAR |
| 2024-02-28 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2024-02-16 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2023-09-05 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2020-05-27 | Tempest Therapeutics, Inc. (MLND) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-11 | Tempest Therapeutics, Inc. (MLND) Delisted | Grant (A) | — | $0 | EDGAR |